William S. Weintraub

57.9k total citations · 10 hit papers
539 papers, 31.5k citations indexed

About

William S. Weintraub is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, William S. Weintraub has authored 539 papers receiving a total of 31.5k indexed citations (citations by other indexed papers that have themselves been cited), including 385 papers in Cardiology and Cardiovascular Medicine, 242 papers in Surgery and 154 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in William S. Weintraub's work include Coronary Interventions and Diagnostics (172 papers), Cardiac Imaging and Diagnostics (154 papers) and Acute Myocardial Infarction Research (145 papers). William S. Weintraub is often cited by papers focused on Coronary Interventions and Diagnostics (172 papers), Cardiac Imaging and Diagnostics (154 papers) and Acute Myocardial Infarction Research (145 papers). William S. Weintraub collaborates with scholars based in United States, Canada and United Kingdom. William S. Weintraub's co-authors include Robert A. Guyton, Ellis L. Jones, Spencer B. King, John A. Spertus, Joseph M. Craver, Andrzej S. Kosinski, Ralph G. Brindis, John S. Douglas, Leslee J. Shaw and Richard E. Shaw and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

William S. Weintraub

524 papers receiving 30.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults

2010 1.4k citations William S. Weintraub et al. Circulation profile →
Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban

2001 1.4k citations William S. Weintraub et al. profile →
Status of Hypertension in China

2018 1.2k citations William S. Weintraub et al. Circulation profile →
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults

2010 982 citations William S. Weintraub et al. Journal of the American College of Cardiology profile →
Beneficial Effects of Cholesterol-Lowering Therapy on the Coronary Endothelium in Patients with Coronary Artery Disease

1995 894 citations William S. Weintraub et al. profile →
American College of Cardiology/American Heart Association expert consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease

2000 575 citations William S. Weintraub, William S. Weintraub et al. Journal of the American College of Cardiology profile →
Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty.

1988 516 citations Spencer B. King, William S. Weintraub et al. Circulation profile →
A Randomized Trial Comparing Coronary Angioplasty with Coronary Bypass Surgery

1994 494 citations Spencer B. King, William S. Weintraub et al. profile →
Elevation of C-reactive protein in “active” coronary artery disease

1990 483 citations William S. Weintraub et al. The American Journal of Cardiology profile →
Effect of PCI on Quality of Life in Patients with Stable Coronary Disease

2008 434 citations William S. Weintraub, John A. Spertus et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William S. Weintraub United States	88	21.2k	14.0k	8.2k	3.5k	2.7k	539	31.5k
Mark A. Hlatky United States	85	23.8k 1.1×	8.3k 0.6×	6.6k 0.8×	2.8k 0.8×	2.6k 1.0×	406	36.4k
Raymond J. Gibbons United States	73	22.6k 1.1×	9.3k 0.7×	12.3k 1.5×	2.5k 0.7×	2.5k 0.9×	343	33.9k
Paul W. Armstrong Canada	93	27.5k 1.3×	9.6k 0.7×	7.7k 0.9×	2.3k 0.7×	3.6k 1.3×	850	38.3k
Robert M. Califf United States	81	23.3k 1.1×	6.9k 0.5×	6.0k 0.7×	2.8k 0.8×	1.8k 0.7×	284	28.8k
Elliott M. Antman United States	108	49.4k 2.3×	17.3k 1.2×	11.3k 1.4×	2.7k 0.8×	2.8k 1.0×	527	61.0k
Khurram Nasir United States	88	14.4k 0.7×	7.5k 0.5×	11.5k 1.4×	2.9k 0.8×	2.8k 1.0×	811	29.7k
Debabrata Mukherjee United States	61	21.0k 1.0×	11.6k 0.8×	6.6k 0.8×	3.5k 1.0×	1.5k 0.5×	466	29.8k
Keith A.A. Fox United Kingdom	109	47.7k 2.2×	15.5k 1.1×	11.2k 1.4×	3.5k 1.0×	2.7k 1.0×	834	59.8k
Bernard Chaitman United States	91	30.7k 1.4×	14.4k 1.0×	14.6k 1.8×	3.6k 1.0×	2.3k 0.8×	353	41.9k
Harvey D. White New Zealand	99	45.2k 2.1×	21.6k 1.5×	14.0k 1.7×	4.2k 1.2×	3.1k 1.1×	719	57.9k

Countries citing papers authored by William S. Weintraub

Since Specialization

Citations

This map shows the geographic impact of William S. Weintraub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William S. Weintraub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William S. Weintraub more than expected).

Fields of papers citing papers by William S. Weintraub

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William S. Weintraub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William S. Weintraub. The network helps show where William S. Weintraub may publish in the future.

Co-authorship network of co-authors of William S. Weintraub

This figure shows the co-authorship network connecting the top 25 collaborators of William S. Weintraub. A scholar is included among the top collaborators of William S. Weintraub based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William S. Weintraub. William S. Weintraub is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fong, Allan, et al.. (2025). Invasive blood pressure monitoring does not improve survival in septic critically ill patients. The American Journal of Emergency Medicine. 94. 173–178.

Moran, Andrew E., Yiyi Zhang, Jordana B. Cohen, et al.. (2024). Effectiveness of Hypertension Management Strategies in SPRINT‐Eligible US Adults: A Simulation Study. Journal of the American Heart Association. 13(2). e032370–e032370. 5 indexed citations

Medranda, Giorgio A., Brian C. Case, Charan Yerasi, et al.. (2021). Implications of Left Ventricular Function on Short-Term Outcomes in COVID-19 Patients With Myocardial Injury. Cardiovascular revascularization medicine. 29. 45–49. 4 indexed citations

Medranda, Giorgio A., Cheng Zhang, Gheorghe Doros, et al.. (2021). Meta-Analysis of Usefulness of Antiplatelet Therapy in Ischemic Stroke or Transient Ischemic Attack. The American Journal of Cardiology. 153. 129–134. 4 indexed citations

Yerasi, Charan, Brian C. Case, Brian J. Forrestal, et al.. (2020). Risk of Mortality with Paclitaxel Drug-Coated Balloon in De Novo Coronary Artery Disease. Cardiovascular revascularization medicine. 21(4). 549–555. 2 indexed citations

Gajanana, Deepakraj, William S. Weintraub, Paul Kolm, et al.. (2019). Trends in Death Rate 2009 to 2018 Following Percutaneous Coronary Intervention Stratified by Acuteness of Presentation. The American Journal of Cardiology. 124(9). 1349–1356. 9 indexed citations

Maron, David J., G.B. John Mancini, Pamela Hartigan, et al.. (2018). Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial. Journal of the American College of Cardiology. 72(19). 2297–2305. 32 indexed citations

Stewart, Simon, Bárbara Riegel, Cynthia M. Boyd, et al.. (2016). Establishing a pragmatic framework to optimise health outcomes in heart failure and multimorbidity (ARISE-HF): A multidisciplinary position statement. International Journal of Cardiology. 212. 1–10. 37 indexed citations

Packard, Chris J., William S. Weintraub, & Ulrich Laufs. (2015). New metrics needed to visualize the long-term impact of early LDL-C lowering on the cardiovascular disease trajectory. Vascular Pharmacology. 71. 37–39. 21 indexed citations

10.

Sidhu, Mandeep S., Pamela Hartigan, Koon Teo, et al.. (2013). Abstract 18129: Sex-Based Comparison of Angina Severity, Extent of Inducible Ischemia, and Burden of Angiographic Coronary Disease: A Post Hoc Analysis of the COURAGE Trial. Circulation. 128(suppl_22). 1 indexed citations

11.

Rao, Sunil V., David Dai, Sumeet Subherwal, et al.. (2012). Association Between Periprocedural Bleeding and Long-Term Outcomes Following Percutaneous Coronary Intervention in Older Patients. JACC: Cardiovascular Interventions. 5(9). 958–965. 63 indexed citations

12.

Chin, Chee Tang, William S. Weintraub, David Dai, et al.. (2011). Trends and predictors of length of stay after primary percutaneous coronary intervention: A report from the CathPCI Registry. American Heart Journal. 162(6). 1052–1061. 23 indexed citations

13.

Ehrenthal, Deborah B., Claudine Jurkovitz, Matthew Hoffman, Xiaozhang Jiang, & William S. Weintraub. (2010). Prepregnancy Body Mass Index as an Independent Risk Factor for Pregnancy-Induced Hypertension. Journal of Women s Health. 20(1). 67–72. 52 indexed citations

14.

Zhang, Zefeng, Elizabeth M. Mahoney, Paul Kolm, et al.. (2010). Cost Effectiveness of Eplerenone in Patients with Heart Failure after Acute Myocardial Infarction Who were Taking Both ACE Inhibitors and β-Blockers. American Journal of Cardiovascular Drugs. 10(1). 55–63. 16 indexed citations

15.

Elliott, Daniel, Liping Zhao, Susan E. Jasper, et al.. (2008). Health status outcomes after cardioversion for atrial fibrillation: Results from the Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) II Trial. American Heart Journal. 156(2). 374.e1–374.e6. 3 indexed citations

16.

Jaime, J., Kristen Migliaccio–Walle, K. Jack Ishak, & William S. Weintraub. (2004). 889-3 Estimating life-years lost due to atherothrombotic events: Flexible survival functions for use in disease modeling. Journal of the American College of Cardiology. 43(5). A425–A425. 6 indexed citations

17.

Weintraub, William S., et al.. (2003). Influence of co-morbidity on cost of care for heart failure. The American Journal of Cardiology. 91(8). 1011–1015. 8 indexed citations

18.

Dreifus, Leonard S., et al.. (2000). Technological advances and the next 50 years of cardiology: Glossary. Journal of the American College of Cardiology. 35(5). 88B–90B. 2 indexed citations

19.

Krawczynska, Elizabeth, et al.. (1997). Prognosis in Patients With Left Ventricular Apical Aneurysm Diagnosed by Thallium-201 or Tc-99m Sestamibi SPECT Images. The American Journal of Cardiology. 79(4). 406–411. 5 indexed citations

20.

Ghazzal, Ziyad M.B., William S. Weintraub, Frank Litvack, et al.. (1995). Predictors of restenosis after excimer laser coronary angioplasty. The American Journal of Cardiology. 75(15). 1012–1014. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact